Tessella demonstated its Crystallographic Information System (CrysIS) at PSDI 2008, the annual Protein Structure Determination in Industry conference for structural biologists working in the pharmaceutical industry.

CrysIS manages the data and workflow of X-Ray protein crystallography from a request for a protein-compound, through the experiment and the final deposition of a protein-ligand structure, and the subsequent exploitation of that structure data.

A typical pharmaceutical organization will produce hundreds of protein-ligand (PDB) structures per year. The workflow associated with this process is complex and results in a large quantity of data that is utilized by structural chemists and medicinal and computational chemists alike. Planning the work of structural chemists across multiple projects within an organization can therefore be a difficult task. Identifying those attributes that lead to a successful experiment is difficult without ready access to previous experimental results. With such a complex workflow, and without the use of appropriate tools, the possibility for manual transcription errors is increased.

This years PSDi conference was organized by GSK and was held at the Hilton Stansted, London.  The conference was themed around issues reflecting the ever increasing pace of change the pharmaceutical industry experiences and the challenges it currently faces. 

For more information on CrysIS, please visit http://www.tessella.com/wp-content/uploads/2008/11/e_crysis.pdf

Relates to: drug-discovery

This entry was posted in Events.